Form 10-Q TREACE MEDICAL CONCEPTS, For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/15/2026
- Wall St futures tick up as investors weigh earnings; PayPal jumps
- PayPal rallies 20% on report Stripe, Advent made $53 billion bid
- Oil prices rise as hostilities worsen in the Middle East
- ASML capacity upgrade soothes AI chip bottleneck fears
- Dollar steadies as Middle East escalation counters soft US inflation
- IBM misses Q2 targets as mainframe and software sales disappoint
- Verizon planning new round of layoffs this week - Barron’s
- Kosovo bans Serb minister over ethnic cleansing remarks
- Lucid Group shares quickly cut in half on report of potential bankruptcy
- S&P 500 and Nasdaq end higher on cool inflation data, solid bank earnings
Morgan Stanley Downgrades Treace Medical Concepts Inc (TMCI) to Equalweight
May 8, 2024 9:30 AM EDTMorgan Stanley analyst Drew Ranieri downgraded Treace Medical Concepts Inc (NASDAQ: TMCI) from Overweight to Equalweight with a price target of $5.50 (from $15.00).
The analyst comments "Competitive disruptions are hitting Treace's commercial momentum with the company now playing innovation catch up, lowering our... More
Truist Securities Downgrades Treace Medical Concepts Inc (TMCI) to Hold
May 8, 2024 6:45 AM EDTTruist Securities analyst Richard Newitter downgraded Treace Medical Concepts Inc (NASDAQ: TMCI) from Buy to Hold with a price target of $7.00 (from $17.00).
The analyst comments "We downgrade TMCI to Hold from Buy on a reduced growth outlook & projected deceleration trend in 2Q24/2024 due... More
Stifel Downgrades Treace Medical Concepts Inc (TMCI) to Hold
May 8, 2024 6:03 AM EDTStifel analyst Rick Wise downgraded Treace Medical Concepts Inc (NASDAQ: TMCI) from Buy to Hold with a price target of $6.00 (from $15.00).
The analyst comments "We are downgrading TMCI to Hold and lowering our price target to $6 from $15, as multiple increasing competitive headwinds have added incremental... More
BTIG Downgrades Treace Medical Concepts Inc (TMCI) to Neutral
May 8, 2024 5:26 AM EDTBTIG analyst Ryan Zimmerman downgraded Treace Medical Concepts Inc (NASDAQ: TMCI) from Buy to Neutral.
The analyst comments "We are downgrading TMCI shares to Neutral and removing our PT following TMCI's 1Q24 results. Quarterly results were fine as TMCI reported rev. of $51.1M (21.1% Y/Y), above BTIG/Consensus est. of $49.1M/$49.1M as a seasonally strong 4Q extended into the early part of the year. However, increasing pressure from competitors offering osteotomy-specific... More
JPMorgan Downgrades Treace Medical Concepts Inc (TMCI) to Neutral
May 8, 2024 5:01 AM EDTJPMorgan analyst Robbie Marcus downgraded Treace Medical Concepts Inc (NASDAQ: TMCI) from Overweight to Neutral with a price target of $8.00 (from $15.00).
The analyst comments "Treace reported a disappointing update after the close on Tuesday as a good quarter came alongside a significant cut to guidance due to growing competitive headwinds. Starting with the quarter, sales of $51.1M (+21%) came... More
